Ignite Creation Date:
2025-12-24 @ 12:58 PM
Ignite Modification Date:
2025-12-28 @ 5:10 PM
Study NCT ID:
NCT02820961
Status:
COMPLETED
Last Update Posted:
2021-12-15
First Post:
2016-06-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer
Sponsor:
Syndax Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Breast Neoplasms | View |
| None | Breast Diseases | View |
| None | Exemestane | View |
| None | Protein Kinase Inhibitors | View |
| None | Aromatase Inhibitors | View |
| None | entinostat | View |
| None | Cancer of the Breast | View |
| None | Metastatic Breast Cancer | View |
| None | Hormone Receptor Positive Breast Cancer | View |
| None | Estrogen Receptor | View |
| None | ER+ Breast Cancer | View |
| None | Breast Tumor | View |